Very Rare Cancer Consortium Disease Spotlight & Research Roundtable

Please join us for the Very Rare Cancer Consortium Tumor Board Meeting. This new initiative aims to bring cancer researchers across New York to the table to discuss compelling rare cancer cases presented by physicians and scientists from the New York Genome Center’s partner institutions. Click here to learn more about the Very Rare Cancer Consortium.

WHEN:
Thursday, June 24, 2021
4pm – 6pm

HEPATOBLASTOMA

Disease Spotlight & Research Roundtable

This will be a VIRTUAL meeting via Zoom.
Please note registration is required.

Hepatoblastoma is the most common liver neoplasm in children and accounts for 1% of all childhood malignancies. Over the last decade, the incidence of Hepatoblastoma has nearly doubled, faster than any other childhood cancer, however in this time we have gained little ground in understanding the molecular characteristics that drive the disease. The five-year survival for Hepatoblastoma is estimated at 60-70%, one of the lowest survival rates for childhood cancer, demanding translational studies to improve our understanding of the disease and enable the development of targeted and more effective clinical therapies.

During this VRCC Roundtable focused on Hepatoblastoma, we will hear from a panel of experts and discuss our current understanding of the disease, advances being made in treatment and research, studies needed to improve patient care, and how we might be able to work together to move to field forward.

SPEAKERS 

Robert E. Schwartz, MD, PhD Assistant Professor of Medicine Division of Gastroenterology and Hepatology Weill Cornell Medicine

Allison O’Neill, MD Clinical Director, Solid Tumor Center Director of Medical Therapies, Liver Tumor CenterSenior Physician Dana-Farber/Boston Children’s Cancer and Blood Disorders CenterAssistant Professor of Pediatrics Harvard Medical School

Dolores López-Terrada, MD, PhD Professor of Pathology and Pediatrics Baylor College of Medicine Division Chief, Genomic Medicine Texas Children’s Hospital Department of Pathology

Logan G. Spector, PhD Suzanne Holmes Hodder Chair in Pediatric Cancer Research Director, Division of Epidemiology/Clinical Research Department of Pediatrics University of Minnesota

Eiso Hiyama, MD, PhD Professor, Department of Pediatric Surgery Hiroshima University HospitalDirector, Natural Science Center for Basic Research and Development (N-BARD) Hiroshima University

Shauna L. Houlihan, PhD Associate Director of Liver Research Englander Institute for Precision Medicine Weill Cornell MedicineScientific Director, Very Rare Cancer Consortium New York Genome Center

James I. Geller, MD Director – Liver, Kidney and Retinoblastoma Programs, Cancer and Blood Diseases Institute Director, Advanced Cancer Therapy Network, Cancer and Blood Disease Institute Director, Pilot Translational Core Grant Program, Center for Clinical and Translational Science and Training Professor, UC Department of Pediatrics Cincinnati Children’s Hospital Medical Center

Discussion

Any questions on this event, contact events@nygenome.org.